Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Clear all

445 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20004
20016
20023
20036
200412
200519
200620
200722
200839
200920
201031
201124
201221
201314
201417
201523
201611
201719
201817
201913
20208
20219
202211
202313
202415
202520
202615

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed324
Terminated49
Recruiting22
Unknown status21
Active, not recruiting10
Withdrawn9
Not yet recruiting8
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
GlaxoSmithKline45
AstraZeneca41
Boehringer Ingelheim33
Chiesi Farmaceutici S.p.A.15
Novartis Pharmaceuticals13
Pearl Therapeutics, Inc.11
Pfizer10
Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA10
Novartis8
Merck Sharp & Dohme LLC7

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive445
Emphysema42
Bronchitis, Chronic28
Asthma22
Lung Diseases15
Dyspnea13
Respiration Disorders12
Hypertension, Pulmonary10
Inflammation9
Respiratory Aspiration9

Trials

Showing 76 to 100 of 445. Each trial links to its page on Pharma Observatory.

345 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.